News jeff 2018-05-31T11:46:02+00:00

News

A first in Taiwan! In collaboration with Taiwanese API and drug product manufacturers, TaiRx produced the first domestically manufactured selenium trace element drug in Taiwan and was approved by the Taiwan FDA.

2018/3/8 TaiRx, Inc. [...]

March 8th, 2018|News|

TaiRx published study results of serum GPx-3 protein levels and associated bioactivity in healthy subjects and sepsis patients in Clinica Chimica Acta.

2017/10/31 Lee WJ, Chen YL, Chu YW, Chien [...]

October 31st, 2017|News|

TaiRx and Northwestern University Ann & Robert H. Lurie Children’s Hospital completed exclusive licensing deal for global development and market rights using Nodal protein as new biomarker to detect malignant tumor also for the treatment of various metastatic cancer.

2017/8/22 TaiRx Announces [...]

August 22nd, 2017|News|

TaiRx held a pre-IPO institutional investors’ conference and announced the listing on Taiwan Emerging Market on the 20th of June.

2017/6/15 TaiRx shows its [...]

June 15th, 2017|News|

TaiRx presents CVM-1118 Phase I Clinical Trial Progress at ASCO

2017/6/5 TaiRx, Inc. (6580) [...]

June 5th, 2017|News|

Previous 234 Next